IMMU-21. THE COMBINATION OF DELTA-24-ACT WITH AN IMMUNE CHECKPOINT INHIBITOR RESULTS IN ANTI-GLIOMA EFFECT AND IMMUNE MEMORY

Oncolytic viruses have become promising therapeutic candidates to treat gliomas. Our group has developed Delta-24-ACT, an oncolytic adenovirus armed with the positive costimulatory ligand 4-1BBL which is capable to trigger the activation of T cells and thereby increase their antitumor immune respons...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Puigdelloses, Montserrat, Laspidea, Virginia, Garcia-Moure, Marc, De la Nava, Daniel, Hambardzumyan, Dolores, Chen, Zhihong, Labiano, Sara, Fueyo, Juan, Gomez-Manzano, Candelaria, de Larraya, Jaime Gállego-pérez, M Alonso, Marta
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651344/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.451
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados